BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6627697)

  • 1. The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
    Delitala G; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):437-44. PubMed ID: 6627697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms involved in the prolactin-releasing effect of benserazide.
    Parati EA; Penalva A; Bondiolotti GP; Parenti M; Locatelli V; Picotti GB; Cocchi D; Müller EE
    Eur J Pharmacol; 1984 Jun; 101(3-4):215-21. PubMed ID: 6468496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the hypothalamus in opiate-stimulated prolactin secretion.
    Dobson PR; Brown BL
    Regul Pept; 1988 Apr; 20(4):305-10. PubMed ID: 3368581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two enkephalin analogues, morphine sulphate, dopamine and naloxone on prolactin secretion from rat anterior pituitary glands in vitro.
    Bentley AM; Wallis M
    J Endocrinol; 1986 Jun; 109(3):313-20. PubMed ID: 3734666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic inhibition of prolactin release from pituitary glands of the domestic fowl incubated in vitro.
    Hall TR; Chadwick A
    J Endocrinol; 1984 Oct; 103(1):63-9. PubMed ID: 6434684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TNF-alpha on prolactin secretion from rat anterior pituitary and dopamine release from the hypothalamus: comparison with the effect of interleukin-1 beta.
    Yamaguchi M; Koike K; Yoshimoto Y; Ikegami H; Miyake A; Tanizawa O
    Endocrinol Jpn; 1991 Aug; 38(4):357-61. PubMed ID: 1802676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of pituitary prolactin synthesis and release by the administration of morphine to rats bearing a transplanted prolactin-secreting tumor.
    Login IS; Nagy I; MacLeod RM
    Neuroendocrinology; 1981 Aug; 33(2):101-4. PubMed ID: 7266770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serotonergic mechanism of the prolactin-stimulating action of metoclopramide.
    Fang VS; Shian LR
    Endocrinology; 1981 May; 108(5):1622-7. PubMed ID: 6452260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter effects on release of prolactin and growth hormone in vitro from pituitary glands of the pigeon, Columba livia.
    Hall TR
    J Endocrinol; 1982 Feb; 92(2):303-8. PubMed ID: 6120986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine on the serum prolactin levels of morphine-tolerant and nontolerant male rats and of the in vitro release of pituitary prolactin.
    Muraki T; Tokunaga Y
    Jpn J Pharmacol; 1978 Dec; 28(6):803-10. PubMed ID: 745306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro.
    Tagawa R; Takahara J; Sato M; Niimi M; Murao K; Ishida T
    Life Sci; 1992; 51(10):727-32. PubMed ID: 1355255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin release and tuberoinfundibular dopaminergic neuronal activity following single and double injections of morphine.
    Callahan P; Grandison L; Rabii J
    Brain Res; 1986 Aug; 381(1):106-12. PubMed ID: 3489504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopaminergic regulation of anterior pituitary 45Ca2+ homeostasis and prolactin secretion.
    Schrey MP; Clark HJ; Franks S
    J Endocrinol; 1986 Mar; 108(3):423-9. PubMed ID: 3486242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
    Lengyel AM; Grossman A; Bouloux PM; Rees LH; Besser GM
    J Endocrinol; 1985 Sep; 106(3):317-22. PubMed ID: 2864381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
    Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
    Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of neurotensin on anterior pituitary hormone secretion.
    McCann SM; Vijayan E; Koenig J; Krulich L
    Ann N Y Acad Sci; 1982; 400():160-71. PubMed ID: 6820240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of opiates to reverse dopamine inhibition of prolactin secretion in vitro.
    Login IS; Macleod RM
    Eur J Pharmacol; 1979 Dec; 60(2-3):253-5. PubMed ID: 527660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.